Bertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki, Ievgenii Karamanesht, Xavier Leleu, Helgi van de Velde, Huaibao Feng, Andrew Cakana, William Deraedt, and Philippe Moreau. 2012. “Updated Survival Analysis of a Randomized Phase III Study of Subcutaneous Versus Intravenous Bortezomib in Patients With Relapsed Multiple Myeloma”. Haematologica 97 (12). Pavia, Italy, 1925-28. https://doi.org/10.3324/haematol.2012.067793.